A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Clinical trial NCT06045754 · RECRUITING

Trial details

NCT number: NCT06045754
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2024-04-18
Primary completion: 2027-06-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.